BMI1 promotes the progression of laryngeal squamous cell carcinoma (Q39560579)

13 September 2017

title

BMI1 promotes the progression of laryngeal squamous cell carcinoma (English)

1 reference

13 September 2017

0 references

Hui Chen

1 reference

13 September 2017

Liang Zhou

1 reference

13 September 2017

Guanglun Wan

1 reference

13 September 2017

Tonghai Dou

1 reference

13 September 2017

Jie Tian

1 reference

13 September 2017

language of work or name

English

0 references

publication date

11 April 2011

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S1368837511001126?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

https://api.elsevier.com/content/article/PII:S1368837511001126?httpAccept=text/plain

29 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

29 November 2024

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

472-481

1 reference

Epigenetic signatures of stem-cell identity.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi1, stem cells, and senescence regulation

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

BMI1 sustains human glioblastoma multiforme stem cell renewal

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Stem cells and cancer; the polycomb connection

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Stem cells of the skin epithelium

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Stem cells, cancer, and cancer stem cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.ORALONCOLOGY.2011.03.016

29 November 2024

Identifiers

DOI

1 reference

13 September 2017

1 reference